Callan Capital, LLC Bristol Myers Squibb CO Transaction History

Callan Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $274,349 - $311,059	5,718 New	5,718 $310,000
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $121,511 - $135,868	2,099 Added 59.8%	5,609 $325,000
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $4,141 - $4,598	-65 Reduced 1.82%	3,510 $224,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $244,816 - $289,896	3,575 New	3,575 $257,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Callan Capital, LLC with notifications on news.